lithium;1,1-dimethoxy-N,N-dimethylmethanamine;2-hydroxypropanamide;iodomethane;3-[5-(1-methoxyethyl)-1,2,4-triazol-1-yl]-5-(4-methylphenyl)benzoic acid;3-[5-(1-methoxyethyl)-1,2,4-triazol-1-yl]-5-(4-methylphenyl)-N-(1-pyrazin-2-ylethyl)benzamide;methyl 3-hydrazinyl-5-(4-methylphenyl)benzoate;methyl 3-[5-(1-hydroxyethyl)-1,2,4-triazol-1-yl]-5-(4-methylphenyl)benzoate;methyl 3-[5-(1-methoxyethyl)-1,2,4-triazol-1-yl]-5-(4-methylphenyl)benzoate;1-pyrazin-2-ylethanamine;hydroxide

C113H134ILiN22O18 — CID 158064150

IUPAClithium;1,1-dimethoxy-N,N-dimethylmethanamine;2-hydroxypropanamide;iodomethane;3-[5-(1-methoxyethyl)-1,2,4-triazol-1-yl]-5-(4-methylphenyl)benzoic acid;3-[5-(1-methoxyethyl)-1,2,4-triazol-1-yl]-5-(4-methylphenyl)-N-(1-pyrazin-2-ylethyl)benzamide;methyl 3-hydrazinyl-5-(4-methylphenyl)benzoate;methyl 3-[5-(1-hydroxyethyl)-1,2,4-triazol-1-yl]-5-(4-methylphenyl)benzoate;methyl 3-[5-(1-methoxyethyl)-1,2,4-triazol-1-yl]-5-(4-methylphenyl)benzoate;1-pyrazin-2-ylethanamine;hydroxide
SMILESCC(N)c1cnccn1.CC(O)C(N)=O.CI.COC(=O)c1cc(-c2ccc(C)cc2)cc(-n2ncnc2C(C)O)c1.COC(=O)c1cc(-c2ccc(C)cc2)cc(-n2ncnc2C(C)OC)c1.COC(=O)c1cc(NN)cc(-c2ccc(C)cc2)c1.COC(C)c1ncnn1-c1cc(C(=O)NC(C)c2cnccn2)cc(-c2ccc(C)cc2)c1.COC(C)c1ncnn1-c1cc(C(=O)O)cc(-c2ccc(C)cc2)c1.COC(OC)N(C)C.[Li+].[OH-]
InChIInChI=1S/C25H26N6O2.C20H21N3O3.2C19H19N3O3.C15H16N2O2.C6H9N3.C5H13NO2.C3H7NO2.CH3I.Li.H2O/c1-16-5-7-19(8-6-16)20-11-21(25(32)30-17(2)23-14-26-9-10-27-23)13-22(12-20)31-24(18(3)33-4)28-15-29-31;1-13-5-7-15(8-6-13)16-9-17(20(24)26-4)11-18(10-16)23-19(14(2)25-3)21-12-22-23;1-12-4-6-14(7-5-12)15-8-16(19(23)24)10-17(9-15)22-18(13(2)25-3)20-11-21-22;1-12-4-6-14(7-5-12)15-8-16(19(24)25-3)10-17(9-15)22-18(13(2)23)20-11-21-22;1-10-3-5-11(6-4-10)12-7-13(15(18)19-2)9-14(8-12)17-16;1-5(7)6-4-8-2-3-9-6;1-6(2)5(7-3)8-4;1-2(5)3(4)6;1-2;;/h5-15,17-18H,1-4H3,(H,30,32);5-12,14H,1-4H3;4-11,13H,1-3H3,(H,23,24);4-11,13,23H,1-3H3;3-9,17H,16H2,1-2H3;2-5H,7H2,1H3;5H,1-4H3;2,5H,1H3,(H2,4,6);1H3;;1H2/q;;;;;;;;;+1;/p-1
InChIKeyFLADLASNEARXMP-UHFFFAOYSA-M
MW2222.30 g/mol
LogP14.78
Rot. Bonds29

About lithium;1,1-dimethoxy-N,N-dimethylmethanamine;2-hydroxypropanamide;iodomethane;3-[5-(1-methoxyethyl)-1,2,4-triazol-1-yl]-5-(4-methylphenyl)benzoic acid;3-[5-(1-methoxyethyl)-1,2,4-triazol-1-yl]-5-(4-methylphenyl)-N-(1-pyrazin-2-ylethyl)benzamide;methyl 3-hydrazinyl-5-(4-methylphenyl)benzoate;methyl 3-[5-(1-hydroxyethyl)-1,2,4-triazol-1-yl]-5-(4-methylphenyl)benzoate;methyl 3-[5-(1-methoxyethyl)-1,2,4-triazol-1-yl]-5-(4-methylphenyl)benzoate;1-pyrazin-2-ylethanamine;hydroxide

lithium;1,1-dimethoxy-N,N-dimethylmethanamine;2-hydroxypropanamide;iodomethane;3-[5-(1-methoxyethyl)-1,2,4-triazol-1-yl]-5-(4-methylphenyl)benzoic acid;3-[5-(1-methoxyethyl)-1,2,4-triazol-1-yl]-5-(4-methylphenyl)-N-(1-pyrazin-2-ylethyl)benzamide;methyl 3-hydrazinyl-5-(4-methylphenyl)benzoate;methyl 3-[5-(1-hydroxyethyl)-1,2,4-triazol-1-yl]-5-(4-methylphenyl)benzoate;methyl 3-[5-(1-methoxyethyl)-1,2,4-triazol-1-yl]-5-(4-methylphenyl)benzoate;1-pyrazin-2-ylethanamine;hydroxide (PubChem CID 158064150) has the molecular formula C113H134ILiN22O18 and a molecular weight of 2222.30 g/mol. Its IUPAC name is lithium;1,1-dimethoxy-N,N-dimethylmethanamine;2-hydroxypropanamide;iodomethane;3-[5-(1-methoxyethyl)-1,2,4-triazol-1-yl]-5-(4-methylphenyl)benzoic acid;3-[5-(1-methoxyethyl)-1,2,4-triazol-1-yl]-5-(4-methylphenyl)-N-(1-pyrazin-2-ylethyl)benzamide;methyl 3-hydrazinyl-5-(4-methylphenyl)benzoate;methyl 3-[5-(1-hydroxyethyl)-1,2,4-triazol-1-yl]-5-(4-methylphenyl)benzoate;methyl 3-[5-(1-methoxyethyl)-1,2,4-triazol-1-yl]-5-(4-methylphenyl)benzoate;1-pyrazin-2-ylethanamine;hydroxide.

Molecular Properties

Compound Namelithium;1,1-dimethoxy-N,N-dimethylmethanamine;2-hydroxypropanamide;iodomethane;3-[5-(1-methoxyethyl)-1,2,4-triazol-1-yl]-5-(4-methylphenyl)benzoic acid;3-[5-(1-methoxyethyl)-1,2,4-triazol-1-yl]-5-(4-methylphenyl)-N-(1-pyrazin-2-ylethyl)benzamide;methyl 3-hydrazinyl-5-(4-methylphenyl)benzoate;methyl 3-[5-(1-hydroxyethyl)-1,2,4-triazol-1-yl]-5-(4-methylphenyl)benzoate;methyl 3-[5-(1-methoxyethyl)-1,2,4-triazol-1-yl]-5-(4-methylphenyl)benzoate;1-pyrazin-2-ylethanamine;hydroxide
PubChem CID158064150
Molecular FormulaC113H134ILiN22O18
Molecular Weight2222.30 g/mol
Exact Mass2220.95
IUPAC Namelithium;1,1-dimethoxy-N,N-dimethylmethanamine;2-hydroxypropanamide;iodomethane;3-[5-(1-methoxyethyl)-1,2,4-triazol-1-yl]-5-(4-methylphenyl)benzoic acid;3-[5-(1-methoxyethyl)-1,2,4-triazol-1-yl]-5-(4-methylphenyl)-N-(1-pyrazin-2-ylethyl)benzamide;methyl 3-hydrazinyl-5-(4-methylphenyl)benzoate;methyl 3-[5-(1-hydroxyethyl)-1,2,4-triazol-1-yl]-5-(4-methylphenyl)benzoate;methyl 3-[5-(1-methoxyethyl)-1,2,4-triazol-1-yl]-5-(4-methylphenyl)benzoate;1-pyrazin-2-ylethanamine;hydroxide
SMILESCC(N)c1cnccn1.CC(O)C(N)=O.CI.COC(=O)c1cc(-c2ccc(C)cc2)cc(-n2ncnc2C(C)O)c1.COC(=O)c1cc(-c2ccc(C)cc2)cc(-n2ncnc2C(C)OC)c1.COC(=O)c1cc(NN)cc(-c2ccc(C)cc2)c1.COC(C)c1ncnn1-c1cc(C(=O)NC(C)c2cnccn2)cc(-c2ccc(C)cc2)c1.COC(C)c1ncnn1-c1cc(C(=O)O)cc(-c2ccc(C)cc2)c1.COC(OC)N(C)C.[Li+].[OH-]
InChIInChI=1S/C25H26N6O2.C20H21N3O3.2C19H19N3O3.C15H16N2O2.C6H9N3.C5H13NO2.C3H7NO2.CH3I.Li.H2O/c1-16-5-7-19(8-6-16)20-11-21(25(32)30-17(2)23-14-26-9-10-27-23)13-22(12-20)31-24(18(3)33-4)28-15-29-31;1-13-5-7-15(8-6-13)16-9-17(20(24)26-4)11-18(10-16)23-19(14(2)25-3)21-12-22-23;1-12-4-6-14(7-5-12)15-8-16(19(23)24)10-17(9-15)22-18(13(2)25-3)20-11-21-22;1-12-4-6-14(7-5-12)15-8-16(19(24)25-3)10-17(9-15)22-18(13(2)23)20-11-21-22;1-10-3-5-11(6-4-10)12-7-13(15(18)19-2)9-14(8-12)17-16;1-5(7)6-4-8-2-3-9-6;1-6(2)5(7-3)8-4;1-2(5)3(4)6;1-2;;/h5-15,17-18H,1-4H3,(H,30,32);5-12,14H,1-4H3;4-11,13H,1-3H3,(H,23,24);4-11,13,23H,1-3H3;3-9,17H,16H2,1-2H3;2-5H,7H2,1H3;5H,1-4H3;2,5H,1H3,(H2,4,6);1H3;;1H2/q;;;;;;;;;+1;/p-1
InChIKeyFLADLASNEARXMP-UHFFFAOYSA-M
XLogP14.78
TPSA546.71 Ų
H-Bond Donors8
H-Bond Acceptors37
Rotatable Bonds29
Heavy Atoms155
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002222.30
LogP ≤ 514.78
H-Bond Donors ≤ 58
H-Bond Acceptors ≤ 1037

Computed Properties (RDKit)

Structural Alerts{'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}, {'alert_name': 'alkyl_halide', 'substructure': 'N/A'}, {'alert_name': 'het-C-het_not_in_ring', 'substructure': 'N/A'}, {'alert_name': 'hydrazine', 'substructure': 'N/A'}, {'alert_name': 'iodine', 'substructure': 'N/A'}

Analyze lithium;1,1-dimethoxy-N,N-dimethylmethanamine;2-hydroxypropanamide;iodomethane;3-[5-(1-methoxyethyl)-1,2,4-triazol-1-yl]-5-(4-methylphenyl)benzoic acid;3-[5-(1-methoxyethyl)-1,2,4-triazol-1-yl]-5-(4-methylphenyl)-N-(1-pyrazin-2-ylethyl)benzamide;methyl 3-hydrazinyl-5-(4-methylphenyl)benzoate;methyl 3-[5-(1-hydroxyethyl)-1,2,4-triazol-1-yl]-5-(4-methylphenyl)benzoate;methyl 3-[5-(1-methoxyethyl)-1,2,4-triazol-1-yl]-5-(4-methylphenyl)benzoate;1-pyrazin-2-ylethanamine;hydroxide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

lithium;1,1-dimethoxy-N,N-dimethylmethanamine;2-hydroxypropanamide;iodomethane;3-[5-(1-methoxyethyl)-1,2,4-triazol-1-yl]-5-(4-methylphenyl)benzoic acid;1-[3-[5-(1-methoxyethyl)-1,2,4-triazol-1-yl]-5-(4-methylphenyl)phenyl]-3-pyrazin-2-ylbutan-1-one;methyl 3-hydrazinyl-5-(4-methylphenyl)benzoate;methyl 3-[5-(1-hydroxyethyl)-1,2,4-triazol-1-yl]-5-(4-methylphenyl)benzoate;methyl 3-[5-(1-methoxyethyl)-1,2,4-triazol-1-yl]-5-(4-methylphenyl)benzoate;1-pyrazin-2-ylethanamine;hydroxide
CID 157575175
3-[5-(1-methoxyethyl)-1,2,4-triazol-1-yl]-5-(4-methylphenyl)benzoic acid;3-[5-(1-methoxyethyl)-1,2,4-triazol-1-yl]-5-(4-methylphenyl)-N-(1-pyrazin-2-ylethyl)benzamide
CID 158508808
Disodium;methyl 3-amino-5-(4-methylphenyl)benzoate;methyl 3-hydrazinyl-5-(4-methylphenyl)benzoate;bis(3-(4-methylphenyl)-5-(5-propan-2-yl-1,2,4-triazol-1-yl)benzoic acid);2-methylpropanamide;(5-methylpyrazin-2-yl)methanamine;3-(5-methylpyrazin-2-yl)-1-[3-(5-methyl-2-pyridinyl)-5-(5-propan-2-yl-1,2,4-triazol-1-yl)phenyl]propan-1-one;hydroxide;nitrite;hydrochloride
CID 158917076
lithium;N-(dimethylaminomethylidene)-2-methylpropanamide;methyl 3-hydrazinyl-5-(4-methylphenyl)benzoate;methyl 3-(4-methylphenyl)-5-(5-propan-2-yl-1,2,4-triazol-1-yl)benzoate;3-(4-methylphenyl)-5-(5-propan-2-yl-1,2,4-triazol-1-yl)benzoic acid;1-[3-(4-methylphenyl)-5-(5-propan-2-yl-1,2,4-triazol-1-yl)phenyl]-3-pyrazin-2-ylbutan-1-one;1-pyrazin-2-ylethanamine;hydroxide
CID 160504272
lithium;2-ethyl-1H-imidazole;3-(2-ethylimidazol-1-yl)-5-(4-methylphenyl)benzoic acid;3-(2-ethylimidazol-1-yl)-5-(4-methylphenyl)-N-(1-pyrazin-2-ylethyl)benzamide;iodocopper;methyl 3-(2-ethylimidazol-1-yl)-5-(4-methylphenyl)benzoate;methyl 3-iodo-5-(4-methylphenyl)benzoate;1-pyrazin-2-ylethanamine;hydroxide
CID 160728814
dipotassium;2-aminoethanol;ethyl 4-[3-(3-pyrazol-1-ylphenyl)imidazo[1,2-b]pyridazin-7-yl]benzoate;hydride;N-(2-hydroxyethyl)-4-[3-(3-pyrazol-1-ylphenyl)imidazo[1,2-b]pyridazin-7-yl]benzamide;oxido formate
CID 161532196
sodium;1,1-dimethoxy-N,N-dimethylethanamine;methyl 3-amino-5-(4-methylphenyl)benzoate;methyl 3-(4-methylphenyl)-5-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)benzoate;3-(4-methylphenyl)-5-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)benzoic acid;3-(4-methylphenyl)-5-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)-N-(1-pyrazin-2-ylethyl)benzamide;2-methylpropanehydrazide;1-pyrazin-2-ylethanamine;hydroxide
CID 161988485
lithium;N-(dimethylaminomethylidene)-2-methylpropanamide;methyl 3-hydrazinyl-5-(4-methylphenyl)benzoate;methyl 3-(4-methylphenyl)-5-(5-propan-2-yl-1,2,4-triazol-1-yl)benzoate;3-(4-methylphenyl)-5-(5-propan-2-yl-1,2,4-triazol-1-yl)benzoic acid;3-(4-methylphenyl)-5-(5-propan-2-yl-1,2,4-triazol-1-yl)-N-(1-pyrazin-2-ylethyl)benzamide;1-pyrazin-2-ylethanamine;hydroxide
CID 162256668

Frequently Asked Questions

What is the IUPAC name of lithium;1,1-dimethoxy-N,N-dimethylmethanamine;2-hydroxypropanamide;iodomethane;3-[5-(1-methoxyethyl)-1,2,4-triazol-1-yl]-5-(4-methylphenyl)benzoic acid;3-[5-(1-methoxyethyl)-1,2,4-triazol-1-yl]-5-(4-methylphenyl)-N-(1-pyrazin-2-ylethyl)benzamide;methyl 3-hydrazinyl-5-(4-methylphenyl)benzoate;methyl 3-[5-(1-hydroxyethyl)-1,2,4-triazol-1-yl]-5-(4-methylphenyl)benzoate;methyl 3-[5-(1-methoxyethyl)-1,2,4-triazol-1-yl]-5-(4-methylphenyl)benzoate;1-pyrazin-2-ylethanamine;hydroxide?
The IUPAC name of lithium;1,1-dimethoxy-N,N-dimethylmethanamine;2-hydroxypropanamide;iodomethane;3-[5-(1-methoxyethyl)-1,2,4-triazol-1-yl]-5-(4-methylphenyl)benzoic acid;3-[5-(1-methoxyethyl)-1,2,4-triazol-1-yl]-5-(4-methylphenyl)-N-(1-pyrazin-2-ylethyl)benzamide;methyl 3-hydrazinyl-5-(4-methylphenyl)benzoate;methyl 3-[5-(1-hydroxyethyl)-1,2,4-triazol-1-yl]-5-(4-methylphenyl)benzoate;methyl 3-[5-(1-methoxyethyl)-1,2,4-triazol-1-yl]-5-(4-methylphenyl)benzoate;1-pyrazin-2-ylethanamine;hydroxide (CID 158064150) is lithium;1,1-dimethoxy-N,N-dimethylmethanamine;2-hydroxypropanamide;iodomethane;3-[5-(1-methoxyethyl)-1,2,4-triazol-1-yl]-5-(4-methylphenyl)benzoic acid;3-[5-(1-methoxyethyl)-1,2,4-triazol-1-yl]-5-(4-methylphenyl)-N-(1-pyrazin-2-ylethyl)benzamide;methyl 3-hydrazinyl-5-(4-methylphenyl)benzoate;methyl 3-[5-(1-hydroxyethyl)-1,2,4-triazol-1-yl]-5-(4-methylphenyl)benzoate;methyl 3-[5-(1-methoxyethyl)-1,2,4-triazol-1-yl]-5-(4-methylphenyl)benzoate;1-pyrazin-2-ylethanamine;hydroxide.
What is the SMILES notation for lithium;1,1-dimethoxy-N,N-dimethylmethanamine;2-hydroxypropanamide;iodomethane;3-[5-(1-methoxyethyl)-1,2,4-triazol-1-yl]-5-(4-methylphenyl)benzoic acid;3-[5-(1-methoxyethyl)-1,2,4-triazol-1-yl]-5-(4-methylphenyl)-N-(1-pyrazin-2-ylethyl)benzamide;methyl 3-hydrazinyl-5-(4-methylphenyl)benzoate;methyl 3-[5-(1-hydroxyethyl)-1,2,4-triazol-1-yl]-5-(4-methylphenyl)benzoate;methyl 3-[5-(1-methoxyethyl)-1,2,4-triazol-1-yl]-5-(4-methylphenyl)benzoate;1-pyrazin-2-ylethanamine;hydroxide?
The canonical SMILES for lithium;1,1-dimethoxy-N,N-dimethylmethanamine;2-hydroxypropanamide;iodomethane;3-[5-(1-methoxyethyl)-1,2,4-triazol-1-yl]-5-(4-methylphenyl)benzoic acid;3-[5-(1-methoxyethyl)-1,2,4-triazol-1-yl]-5-(4-methylphenyl)-N-(1-pyrazin-2-ylethyl)benzamide;methyl 3-hydrazinyl-5-(4-methylphenyl)benzoate;methyl 3-[5-(1-hydroxyethyl)-1,2,4-triazol-1-yl]-5-(4-methylphenyl)benzoate;methyl 3-[5-(1-methoxyethyl)-1,2,4-triazol-1-yl]-5-(4-methylphenyl)benzoate;1-pyrazin-2-ylethanamine;hydroxide is CC(N)c1cnccn1.CC(O)C(N)=O.CI.COC(=O)c1cc(-c2ccc(C)cc2)cc(-n2ncnc2C(C)O)c1.COC(=O)c1cc(-c2ccc(C)cc2)cc(-n2ncnc2C(C)OC)c1.COC(=O)c1cc(NN)cc(-c2ccc(C)cc2)c1.COC(C)c1ncnn1-c1cc(C(=O)NC(C)c2cnccn2)cc(-c2ccc(C)cc2)c1.COC(C)c1ncnn1-c1cc(C(=O)O)cc(-c2ccc(C)cc2)c1.COC(OC)N(C)C.[Li+].[OH-].
What is the InChIKey of lithium;1,1-dimethoxy-N,N-dimethylmethanamine;2-hydroxypropanamide;iodomethane;3-[5-(1-methoxyethyl)-1,2,4-triazol-1-yl]-5-(4-methylphenyl)benzoic acid;3-[5-(1-methoxyethyl)-1,2,4-triazol-1-yl]-5-(4-methylphenyl)-N-(1-pyrazin-2-ylethyl)benzamide;methyl 3-hydrazinyl-5-(4-methylphenyl)benzoate;methyl 3-[5-(1-hydroxyethyl)-1,2,4-triazol-1-yl]-5-(4-methylphenyl)benzoate;methyl 3-[5-(1-methoxyethyl)-1,2,4-triazol-1-yl]-5-(4-methylphenyl)benzoate;1-pyrazin-2-ylethanamine;hydroxide?
The InChIKey is FLADLASNEARXMP-UHFFFAOYSA-M. The full InChI is InChI=1S/C25H26N6O2.C20H21N3O3.2C19H19N3O3.C15H16N2O2.C6H9N3.C5H13NO2.C3H7NO2.CH3I.Li.H2O/c1-16-5-7-19(8-6-16)20-11-21(25(32)30-17(2)23-14-26-9-10-27-23)13-22(12-20)31-24(18(3)33-4)28-15-29-31;1-13-5-7-15(8-6-13)16-9-17(20(24)26-4)11-18(10-16)23-19(14(2)25-3)21-12-22-23;1-12-4-6-14(7-5-12)15-8-16(19(23)24)10-17(9-15)22-18(13(2)25-3)20-11-21-22;1-12-4-6-14(7-5-12)15-8-16(19(24)25-3)10-17(9-15)22-18(13(2)23)20-11-21-22;1-10-3-5-11(6-4-10)12-7-13(15(18)19-2)9-14(8-12)17-16;1-5(7)6-4-8-2-3-9-6;1-6(2)5(7-3)8-4;1-2(5)3(4)6;1-2;;/h5-15,17-18H,1-4H3,(H,30,32);5-12,14H,1-4H3;4-11,13H,1-3H3,(H,23,24);4-11,13,23H,1-3H3;3-9,17H,16H2,1-2H3;2-5H,7H2,1H3;5H,1-4H3;2,5H,1H3,(H2,4,6);1H3;;1H2/q;;;;;;;;;+1;/p-1.
What are the key properties of lithium;1,1-dimethoxy-N,N-dimethylmethanamine;2-hydroxypropanamide;iodomethane;3-[5-(1-methoxyethyl)-1,2,4-triazol-1-yl]-5-(4-methylphenyl)benzoic acid;3-[5-(1-methoxyethyl)-1,2,4-triazol-1-yl]-5-(4-methylphenyl)-N-(1-pyrazin-2-ylethyl)benzamide;methyl 3-hydrazinyl-5-(4-methylphenyl)benzoate;methyl 3-[5-(1-hydroxyethyl)-1,2,4-triazol-1-yl]-5-(4-methylphenyl)benzoate;methyl 3-[5-(1-methoxyethyl)-1,2,4-triazol-1-yl]-5-(4-methylphenyl)benzoate;1-pyrazin-2-ylethanamine;hydroxide?
lithium;1,1-dimethoxy-N,N-dimethylmethanamine;2-hydroxypropanamide;iodomethane;3-[5-(1-methoxyethyl)-1,2,4-triazol-1-yl]-5-(4-methylphenyl)benzoic acid;3-[5-(1-methoxyethyl)-1,2,4-triazol-1-yl]-5-(4-methylphenyl)-N-(1-pyrazin-2-ylethyl)benzamide;methyl 3-hydrazinyl-5-(4-methylphenyl)benzoate;methyl 3-[5-(1-hydroxyethyl)-1,2,4-triazol-1-yl]-5-(4-methylphenyl)benzoate;methyl 3-[5-(1-methoxyethyl)-1,2,4-triazol-1-yl]-5-(4-methylphenyl)benzoate;1-pyrazin-2-ylethanamine;hydroxide has a molecular weight of 2222.30 g/mol, XLogP of 14.78, 29 rotatable bonds, 8 hydrogen bond donors, and 37 hydrogen bond acceptors.
Where does this data come from?
All data for lithium;1,1-dimethoxy-N,N-dimethylmethanamine;2-hydroxypropanamide;iodomethane;3-[5-(1-methoxyethyl)-1,2,4-triazol-1-yl]-5-(4-methylphenyl)benzoic acid;3-[5-(1-methoxyethyl)-1,2,4-triazol-1-yl]-5-(4-methylphenyl)-N-(1-pyrazin-2-ylethyl)benzamide;methyl 3-hydrazinyl-5-(4-methylphenyl)benzoate;methyl 3-[5-(1-hydroxyethyl)-1,2,4-triazol-1-yl]-5-(4-methylphenyl)benzoate;methyl 3-[5-(1-methoxyethyl)-1,2,4-triazol-1-yl]-5-(4-methylphenyl)benzoate;1-pyrazin-2-ylethanamine;hydroxide is sourced from PubChem (CID 158064150), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).